Xcellerant Ventures

Xcellerant Ventures is a venture capital firm located in Scottsdale, Arizona, focused on advancing healthcare innovation. The firm aims to enhance access to healthcare, reduce costs per patient, and improve the quality of treatment. It specializes in making investments in early-stage companies within the med-tech and health-tech sectors, targeting disruptive firms that have the potential to transform the healthcare landscape.

John Shufeldt JD

Partner, Managing Director and Investment Committee

Michael Shufeldt

Founding Member and Principal, Board Member

4 past transactions

DeepLook Medical

Series A in 2024
DeepLook Medical is a medical software. They use shape-recognition software to extract and assemble that data, revealing radiomic features that uniquely reflect tissue morphology. The phenotype database for mammography is a database of breast cancer morphology offered today for research purposes only.

CRISPR QC

Series A in 2024
CRISPR Analytics Platform expands the data and analytics available for CRISPR gene editing, enabling its partners to produce products more quickly. The platform is based on the CRISPR-Chip, a device that is uniquely able to measure CRISPR activity directly.

Lenoss Medical

Series A in 2023
Lenoss Medical specializes in developing innovative surgical and medical instruments aimed at treating spinal fractures. The company offers the osteopearl VBA system, a minimally invasive and cement-free technology that facilitates the natural healing process of bone. This approach is particularly beneficial for osteoporotic patients, as it leverages the body's inherent healing capabilities while minimizing the risk of complications associated with traditional treatments. By focusing on these advanced solutions, Lenoss Medical aims to improve patient outcomes and enhance the overall treatment landscape for spinal injuries.

TruLite Health

Series A in 2023
TruLite Health develops a health equity platform providing multi-level interventions at the point of care and leverages. Its enterprise point of care SaaS platform brings together a proprietary clinical knowledge base of health equity insights and patient-specific clinical and social data sets. This enables care teams to offer actionable clinical, social, and behavioral interventions for diverse populations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.